1-(3-Chlorophenyl)piperazine hydrochloride

Modify Date: 2024-01-02 19:40:26

1-(3-Chlorophenyl)piperazine hydrochloride Structure
1-(3-Chlorophenyl)piperazine hydrochloride structure
Common Name 1-(3-Chlorophenyl)piperazine hydrochloride
CAS Number 65369-76-8 Molecular Weight 233.138
Density 1.193g/cm Boiling Point 336.4ºC at 760 mmHg
Molecular Formula C10H14Cl2N2 Melting Point 210-214 °C (dec.)(lit.)
MSDS Chinese USA Flash Point 157.2ºC
Symbol GHS02 GHS06 GHS08
GHS02, GHS06, GHS08
Signal Word Danger

 Names

Name 1-(3-Chlorophenyl)piperazine hydrochloride
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.193g/cm
Boiling Point 336.4ºC at 760 mmHg
Melting Point 210-214 °C (dec.)(lit.)
Molecular Formula C10H14Cl2N2
Molecular Weight 233.138
Flash Point 157.2ºC
Exact Mass 232.053406
PSA 15.27000
LogP 2.94540
Index of Refraction 1.598-1.600
Storage condition Store at RT

 MSDS

Name: 1-(3-Chlorophenyl)Piperazine Hydrochloride 95%(HPLC) Material Safety Data Sheet
Synonym: None Known
CAS: 65369-76-8
Section 1 - Chemical Product MSDS Name:1-(3-Chlorophenyl)Piperazine Hydrochloride 95%(HPLC) Material Safety Data Sheet
Synonym:None Known

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
65369-76-8 1-(3-Chlorophenyl)Piperazine Hydrochlo 95% 265-718-0
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea.
Inhalation:
Causes respiratory tract irritation. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or alcohol-resistant foam. Use agent most appropriate to extinguish fire.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed.
Avoid ingestion and inhalation. Use with adequate ventilation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 65369-76-8: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white to brown-gray
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 210 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H13ClN2.2HCl
Molecular Weight: 233.14

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 65369-76-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(3-Chlorophenyl)Piperazine Hydrochloride - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 65369-76-8: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 65369-76-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 65369-76-8 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Symbol GHS02 GHS06 GHS08
GHS02, GHS06, GHS08
Signal Word Danger
Hazard Statements H225-H301 + H311 + H331-H370
Precautionary Statements P210-P260-P280-P301 + P310-P311
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Faceshields;Gloves
Hazard Codes Xi: Irritant;
Risk Phrases R36/37/38
Safety Phrases S26-S36-S24/25
RIDADR UN1230 - class 3 - PG 2 - Methanol, solution
WGK Germany 3

 Articles8

More Articles
N-methyl-D-aspartate receptor channel blocker-like discriminative stimulus effects of nitrous oxide gas.

J. Pharmacol. Exp. Ther. 352(1) , 156-65, (2015)

Nitrous oxide (N2O) gas is a widely used anesthetic adjunct in dentistry and medicine that is also commonly abused. Studies have shown that N2O alters the function of the N-methyl-d-aspartate (NMDA), ...

Simultaneous Quantitation of 78 Drugs and Metabolites in Urine with a Dilute-And-Shoot LC-MS-MS Assay.

J. Anal. Toxicol. 39 , 335-46, (2015)

A novel LC-MS-MS assay that simultaneously detects and quantitates 78 drugs and metabolites was developed and validated for chronic pain management. Urine specimen was diluted and mixed with internal ...

1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

Biol. Psychiatry 25(5) , 569-75, (1989)

The affinity of 1-(m-chlorophenyl)piperazine (mCPP) for 11 neurotransmitter receptor binding sites was determined in human brain membranes. mCPP is essentially equipotent at all 5-hydroxytryptamine (5...

 Synonyms

MFCD00039032
Piperazine, 1- (3-chlorophenyl)-, monohydrochloride
1-(3-CHLOROPHENYL)PIPERAZINE 2HCL
N-(3-Chlorophenyl) Piperazine HCl
M-CPP HYDROCHLORIDE
1-(3-CHLORO PHENYL)-PIPERAZINE HCL
1-(3-chlorophenyl)piperazine hydrochlori
1-(3-Chlorophenyl)piperazine (mCPP) HCl
M-CPP
1-(3-Chlorophenyl)piperazine hydrochloride (1:1)
Piperazine, 1-(3-chlorophenyl)-, hydrochloride (1:1)
EINECS 235-976-9
1-(3-CHLOROPHENYL)-PIPERAZINE HCL (MCLPPB)